Vabomere

The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Fierce Pharma
Wed, 11/29/17 - 10:15 am
The Medicines Company
PCSK9 inhibitors
inclisiran
Vabomere